CORDIS
EU research results

CORDIS

English EN

Non-invasive monitoring of perinatal health through multiparametric digital representation of clinically relevant functions for improving clinical intervention in neonatal units (Digi-NewB)

Project information

Grant agreement ID: 689260

Status

Closed project

  • Start date

    1 March 2016

  • End date

    31 May 2020

Funded under:

H2020-EU.3.1.5.

  • Overall budget:

    € 4 457 680,25

  • EU contribution

    € 4 457 680,25

Coordinated by:

GCS HOPITAUX UNIVERSITAIRES GRAND OUEST

France

Objective

Using the clinical and signal data (cardiac and respiratory traces, video quantification of movement and sound) from a large cohort of hospitalised newborn and pregnant women recordings Digi-NewB aims to propose a new decision support system (DSS). This DSS will assist the clinician in his decision-making through non-invasive monitoring of sepsis risk and of cardio-respiratory and neurobehavioral maturations. The objective is to reduce mortality, morbidity and health costs for the hospitalised newborns. More precisely the proposal consist in: i) implementing a large targeted prospective multicentre neonatal cohort, recruited in six university hospitals, ii) identifying the most relevant composite indices to be included in the DSS iii) validating DSS acceptability and usability in the clinical management of the identified complex situations. To achieve these goals, a consortium has been constituted, under the coordination of a paediatric clinical network (GCS HUGO-France), with two SME (Voxygen-France and Syncrophi-Ireland) and four university groups with multidisciplinary expertise: in signal processing (INESC-Portugal and LTSI-UR1 France), in multivariate analyses (TUT-Finland) and in user centred design approach (NUIG-Ireland). The proposed new class of monitoring will lead to development of novel preventive and therapeutic strategies to counteract late diagnosis of sepsis and inappropriate evaluation of maturity. This will result in i) a decrease in sepsis related death and morbidity through early and personalized prescription of antibiotics, ii) a decrease in the risks of severe cardio-respiratory events and inadequate prolongation of hospitalization iii) a decrease in health costs. At the end of the Digi-NewB program the opportunity to productise the results will be evaluated. It would be a strong 'next generation' product which would secure a good market position. Feasibly development work will be carried out by the SME industrial partners.

Coordinator

GCS HOPITAUX UNIVERSITAIRES GRAND OUEST

Address

4 Rue Larrey Chu D Angers
49100 Angers

France

Activity type

Other

EU Contribution

€ 1 150 055,25

Participants (6)

UNIVERSITE DE RENNES I

France

EU Contribution

€ 956 235

TAMPEREEN KORKEAKOULUSAATIO SR

Finland

VOXYGEN SAS

France

EU Contribution

€ 620 000

INESC TEC - INSTITUTO DE ENGENHARIADE SISTEMAS E COMPUTADORES, TECNOLOGIA E CIENCIA

Portugal

EU Contribution

€ 280 000

NATIONAL UNIVERSITY OF IRELAND GALWAY

Ireland

EU Contribution

€ 611 750

SYNCROPHI SYSTEMS LTD

Ireland

EU Contribution

€ 439 640

Project information

Grant agreement ID: 689260

Status

Closed project

  • Start date

    1 March 2016

  • End date

    31 May 2020

Funded under:

H2020-EU.3.1.5.

  • Overall budget:

    € 4 457 680,25

  • EU contribution

    € 4 457 680,25

Coordinated by:

GCS HOPITAUX UNIVERSITAIRES GRAND OUEST

France